tiprankstipranks
ADM Tronics Unlimited Inc (ADMT)
OTHER OTC:ADMT
US Market

ADM Tronics Unlimited (ADMT) AI Stock Analysis

Compare
18 Followers

Top Page

AD

ADM Tronics Unlimited

(OTC:ADMT)

50Neutral
ADM Tronics Unlimited's score is primarily impacted by its challenging financial performance, marked by persistent losses and negative cash flow. The technical analysis suggests a lack of strong momentum in either direction, while the valuation reflects the company's unprofitable status, resulting in a lower overall score.

ADM Tronics Unlimited (ADMT) vs. S&P 500 (SPY)

ADM Tronics Unlimited Business Overview & Revenue Model

Company DescriptionADM Tronics Unlimited (ADMT) is a diversified technology company engaged in the development, manufacturing, and marketing of innovative technologies across multiple sectors. The company primarily focuses on electronics for non-invasive medical devices, therapeutic medical technology, and environmentally friendly chemical products. ADMT leverages its expertise in electronics and materials science to provide solutions that meet the needs of healthcare and industrial applications.
How the Company Makes MoneyADM Tronics Unlimited generates revenue through the sale of its proprietary electronic medical devices and specialized chemical products. Its key revenue streams include the manufacturing and distribution of non-invasive medical devices used in therapeutic and diagnostic applications, as well as environmentally safe chemical solutions for industrial use. The company also engages in contract manufacturing and research and development services for third parties, which provides an additional income source. Strategic partnerships with medical device companies and industrial firms further contribute to its earnings by expanding product reach and enhancing technological capabilities.

ADM Tronics Unlimited Financial Statement Overview

Summary
ADM Tronics Unlimited faces significant financial hurdles, with consistent losses impacting profitability and cash flow. While there are some signs of revenue stabilization, the company's financial position is strained. The balance sheet shows a reasonable debt level, but ongoing net losses and negative cash flow underline the need for strategic adjustments to improve financial health.
Income Statement
45
Neutral
The income statement shows a challenging financial performance with negative net income and declining EBIT and EBITDA margins. Although there is a slight improvement in revenue for the TTM period, the company has been struggling with profitability, as evidenced by consistently negative net income and EBIT over the years.
Balance Sheet
50
Neutral
The balance sheet reflects moderate financial stability with a manageable debt-to-equity ratio. However, the equity ratio has been decreasing, indicating increasing leverage over time. The return on equity remains negative due to persistent net losses, which is a concern for long-term investor returns.
Cash Flow
40
Negative
The cash flow statement highlights a negative free cash flow position, exacerbated by negative operating cash flow. The operating cash flow to net income ratio and free cash flow to net income ratio indicate cash flow challenges, with limited improvements in cash generation relative to income losses.
Breakdown
Dec 2023Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
2.85M3.68M3.21M3.09M3.49M
Gross Profit
1.09M1.66M1.25M1.16M1.57M
EBIT
-601.52K43.43K-1.13M-670.48K-17.81K
EBITDA
-514.02K80.35K-1.02M-506.36K21.75K
Net Income Common Stockholders
-716.85K-96.32K-1.38M-598.28K-95.76K
Balance SheetCash, Cash Equivalents and Short-Term Investments
537.04K1.00M1.04M1.55M1.44M
Total Assets
2.14M3.09M3.25M5.21M5.05M
Total Debt
799.66K752.69K918.31K1.58M757.76K
Net Debt
262.62K-251.04K-120.18K31.20K-680.95K
Total Liabilities
1.45M1.52M1.88M2.46M1.71M
Stockholders Equity
692.39K1.57M1.37M2.76M3.34M
Cash FlowFree Cash Flow
-599.65K125.02K-574.95K-769.64K55.10K
Operating Cash Flow
-585.13K125.02K-574.95K-769.64K69.96K
Investing Cash Flow
-14.52K0.000.000.00-14.86K
Financing Cash Flow
165.18K-258.56K66.50K877.87K-172.07K

ADM Tronics Unlimited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.06
Price Trends
50DMA
0.07
Negative
100DMA
0.08
Negative
200DMA
0.07
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
38.58
Neutral
STOCH
42.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADMT, the sentiment is Negative. The current price of 0.06 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.07, and below the 200-day MA of 0.07, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 38.58 is Neutral, neither overbought nor oversold. The STOCH value of 42.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ADMT.

ADM Tronics Unlimited Risk Analysis

ADM Tronics Unlimited disclosed 17 risk factors in its most recent earnings report. ADM Tronics Unlimited reported the most risks in the “Production” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ADM Tronics Unlimited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (49)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$215.63M32.5816.11%15.35%71.35%
57
Neutral
$1.21B-291.71%26.81%26.47%
51
Neutral
$18.80M-150.28%-11.31%-40.04%
50
Neutral
$4.33M-45.79%0.46%42.86%
49
Neutral
$6.88B0.03-54.83%2.50%24.65%-2.79%
48
Neutral
$127.54M-1.59%-11.61%-22.20%
32
Underperform
$520.28K89.50%-20.28%13.56%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ADMT
ADM Tronics Unlimited
0.06
-0.02
-25.00%
ATEC
Alphatec Holdings
9.29
-3.80
-29.03%
ELMD
Electromed
24.62
7.10
40.53%
IRIX
Iridex
1.13
-1.28
-53.11%
KNDI
Kandi Technologies
1.43
-0.87
-37.83%
PBIO
Pressure Biosciences
0.01
-0.17
-94.44%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.